(Q28272554)

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Vitronectin is not essential for normal mammalian development and fertility.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Physicochemical characterization of human S-protein and its function in the blood coagulation system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Vitronectin (S protein) is associated with platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Measurement of vitronectin content of human spermatozoa and vitronectin concentration within seminal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Vitronectin in Bronchoalveolar Lavage Fluid Is Increased in Patients with Interstitial Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Detection of vitronectin mRNA in tissues and cells of the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Localization of vitronectin in the normal and atherosclerotic human vessel wall

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

1 reference

7 January 2021

Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Structures of the N-linked oligosaccharides on human plasma vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Porcine vitronectin, the most compact form of single-chain vitronectin: the smallest molecular mass among vitronectins was ascribed to deletion and substitution of base pairs, and proteolytic trimming of the peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Nectinepsin: a new extracellular matrix protein of the pexin family. Characterization of a novel cDNA encoding a protein with an RGD cell binding motif.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Somatomedin B: mitogenic activity derived from contaminant epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Structural and functional characterization of vitronectin-derived RGD-containing peptides from human hemofiltrate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The urokinase receptor is a major vitronectin-binding protein on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Sulfation of two tyrosine-residues in human complement S-protein (vitronectin)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Identification of the collagen-binding domain of vitronectin using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Nucleotide sequence and organization of the human S-protein gene: repeating peptide motifs in the "pexin" family and a model for their evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Identification of novel heparin-binding domains of vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The hemopexin-type repeats of human vitronectin are recognized by Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Molecular modeling of protein-glycosaminoglycan interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Plasmin cleavage of vitronectin Identification of the site and consequent attenuation in binding plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The cluster of basic amino acids in vitronectin contributes to its binding of plasminogen activator inhibitor-1: evidence from thrombin-, elastase- and plasmin-cleaved vitronectins and anti-peptide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Vitronectin is phosphorylated by a cAMP-dependent protein kinase released by activation of human platelets with thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Vitronectin exists in two structurally and functionally distinct forms in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Conformational lability of vitronectin: induction of an antigenic change by alpha-thrombin-serpin complexes and by proteolytically modified thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Evidence that conformational changes upon the transition of the native to the modified form of vitronectin are not limited to the heparin binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Characterization of the denaturation and renaturation of human plasma vitronectin. II. Investigation into the mechanism of formation of multimers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

1 reference

7 January 2021

Native and multimeric vitronectin exhibit similar affinity for heparin. Differences in heparin binding properties induced upon denaturation are due to self-association into a multivalent form

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The phosphorylation of the two-chain form of vitronectin by protein kinase A is heparin dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The cell adhesion domain in plasma vitronectin is cryptic.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Vitronectin and its receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Ligand and cation binding are dual functions of a discrete segment of the integrin β3 subunit: Cation displacement is involved in ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

1 reference

7 January 2021

Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: collaborative interactions among integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The extracellular matrix as a cell survival factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Involvement of integrin alpha V gene expression in human melanoma tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

1 reference

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Mechanisms of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Regulation of in vitro capillary tube formation by anti-integrin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Soluble ligands of the alpha v beta 3 integrin mediate enhanced tyrosine phosphorylation of multiple proteins in adherent bovine pulmonary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The vitronectin receptor (alpha v beta 3) is implicated, in cooperation with P-selectin and platelet-activating factor, in the adhesion of monocytes to activated endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

1 reference

7 January 2021

Binding and processing of multimeric vitronectin by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Inhibition of cell adhesion by high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Plasminogen activator expression in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The urokinase receptor is required for human monocyte chemotaxis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Type-1 plasminogen activator inhibitor in human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Regulation of integrin function by the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Molecular organization and function of the complement system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Physarum vitronectin-like protein: an Arg-Gly-Asp-dependent cell-spreading protein with a distinct NH2-terminal sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Vitronectin diversity in evolution but uniformity in ligand binding and size of the core polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

1 reference

7 January 2021

Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

A 30 kD sulfated extracellular matrix protein immunologically crossreactive with vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Binding of Staphylococcus aureus by human serum spreading factor in an in vitro assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

Binding of heparan sulfate to Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

1 reference

7 January 2021

Binding of vitronectin to opa-expressing Neisseria gonorrhoeae mediates invasion of HeLa cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900298-3

7 January 2021